Primary |
Chronic Lymphocytic Leukaemia |
26.2% |
Bone Marrow Conditioning Regimen |
9.6% |
Prophylaxis Against Graft Versus Host Disease |
9.3% |
Stem Cell Transplant |
9.2% |
Acute Myeloid Leukaemia |
6.3% |
Prophylaxis |
5.5% |
Non-hodgkin's Lymphoma |
4.4% |
B-cell Lymphoma |
4.3% |
Antifungal Prophylaxis |
3.4% |
Mantle Cell Lymphoma |
3.3% |
Infection Prophylaxis |
3.0% |
Antiviral Prophylaxis |
2.6% |
Drug Use For Unknown Indication |
2.3% |
Cord Blood Transplant Therapy |
1.9% |
Metastatic Malignant Melanoma |
1.8% |
Immunosuppression |
1.5% |
Bone Marrow Transplant |
1.4% |
B-cell Small Lymphocytic Lymphoma |
1.4% |
Chemotherapy |
1.4% |
Malignant Melanoma |
1.2% |
|
Thrombocytopenia |
9.8% |
Vomiting |
8.2% |
Pyrexia |
7.7% |
Neutropenia |
6.0% |
Sepsis |
6.0% |
Blood Stem Cell Harvest Failure |
5.7% |
Premature Menopause |
5.7% |
Myelodysplastic Syndrome |
5.5% |
Renal Failure |
4.9% |
Progressive Multifocal Leukoencephalopathy |
4.6% |
Respiratory Failure |
4.6% |
Acute Myeloid Leukaemia |
4.1% |
Pancytopenia |
4.1% |
Septic Shock |
3.8% |
White Blood Cell Count Decreased |
3.8% |
Myeloid Leukaemia |
3.3% |
Renal Failure Acute |
3.3% |
Transplant Failure |
3.3% |
Off Label Use |
2.7% |
Pulmonary Oedema |
2.7% |
|
Secondary |
Chronic Lymphocytic Leukaemia |
31.3% |
Drug Use For Unknown Indication |
12.0% |
Product Used For Unknown Indication |
7.0% |
Prophylaxis |
5.4% |
Stem Cell Transplant |
4.9% |
B-cell Lymphoma |
4.7% |
Acute Myeloid Leukaemia |
4.5% |
Non-hodgkin's Lymphoma |
4.5% |
Mantle Cell Lymphoma |
3.6% |
Bone Marrow Conditioning Regimen |
3.4% |
Prophylaxis Against Graft Versus Host Disease |
3.2% |
Lymphoma |
3.1% |
Premedication |
2.7% |
Multiple Myeloma |
1.9% |
Infection Prophylaxis |
1.7% |
Graft Versus Host Disease |
1.4% |
Bone Marrow Transplant |
1.2% |
Acute Lymphocytic Leukaemia |
1.2% |
Immunosuppression |
1.1% |
Ewing's Sarcoma |
1.1% |
|
Febrile Neutropenia |
13.1% |
Myelodysplastic Syndrome |
8.3% |
Progressive Multifocal Leukoencephalopathy |
6.7% |
Sepsis |
6.6% |
Neutropenia |
6.4% |
Pneumonia |
6.2% |
Vomiting |
6.0% |
Pyrexia |
5.7% |
Thrombocytopenia |
4.9% |
White Blood Cell Count Decreased |
4.1% |
Blood Stem Cell Harvest Failure |
3.9% |
Death |
3.9% |
Acute Myeloid Leukaemia |
3.6% |
Septic Shock |
3.6% |
Graft Versus Host Disease |
3.2% |
Pancytopenia |
3.2% |
Respiratory Failure |
3.1% |
Thrombotic Microangiopathy |
2.7% |
Cytomegalovirus Infection |
2.4% |
Premature Menopause |
2.4% |
|
Concomitant |
Product Used For Unknown Indication |
14.1% |
Bone Marrow Conditioning Regimen |
13.3% |
Prophylaxis Against Graft Versus Host Disease |
13.3% |
Stem Cell Transplant |
9.2% |
Infection Prophylaxis |
9.1% |
Prophylaxis |
9.0% |
Chronic Lymphocytic Leukaemia |
3.9% |
Premedication |
3.8% |
Drug Use For Unknown Indication |
3.5% |
Antifungal Prophylaxis |
2.9% |
Cord Blood Transplant Therapy |
2.7% |
Acute Myeloid Leukaemia |
2.4% |
Antibiotic Prophylaxis |
1.9% |
Antiviral Prophylaxis |
1.9% |
Non-hodgkin's Lymphoma |
1.9% |
B-cell Lymphoma |
1.8% |
Graft Versus Host Disease |
1.5% |
Aplastic Anaemia |
1.3% |
Bone Marrow Transplant |
1.3% |
Prophylaxis Of Nausea And Vomiting |
1.2% |
|
Acute Graft Versus Host Disease |
9.5% |
Progressive Multifocal Leukoencephalopathy |
8.9% |
Stomatitis |
7.9% |
Thrombotic Microangiopathy |
7.7% |
Vomiting |
7.4% |
Pyrexia |
7.2% |
Venoocclusive Liver Disease |
6.3% |
Stem Cell Transplant |
5.0% |
Drug Ineffective |
4.7% |
Sepsis |
4.7% |
White Blood Cell Count Decreased |
4.3% |
Death |
3.4% |
Graft Versus Host Disease |
3.2% |
Acute Graft Versus Host Disease In Skin |
3.1% |
Febrile Neutropenia |
3.1% |
Thrombocytopenia |
3.1% |
Septic Shock |
2.8% |
Neutropenia |
2.7% |
Acute Myeloid Leukaemia |
2.6% |
Pneumonia |
2.6% |
|
Interacting |
Lymphoma |
50.0% |
Chronic Lymphocytic Leukaemia |
12.0% |
Epilepsy |
10.0% |
Non-hodgkin's Lymphoma |
10.0% |
Nausea |
8.0% |
Prophylaxis |
4.0% |
Anticoagulant Therapy |
2.0% |
Deep Vein Thrombosis |
2.0% |
Pneumonitis |
2.0% |
|
Nausea |
62.5% |
Anticoagulation Drug Level Above Therapeutic |
12.5% |
Leukopenia |
12.5% |
Sepsis |
12.5% |
|